Abstract
The article discusses the principles of therapy and prospects for the treatment of interstitial lung diseases in children. Many of interstitial lung diseases occur with progressive fibrosis, so the use of new antifibrotic drugs is especially relevant now. These drugs include pirfenidone and nintedanib. Therapy of interstitial lung diseases using antifibrotic drugs in children is a promising new direction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Paper Title
Journal
Date
